These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10348766)

  • 21. Does Cefiderocol Have a Potential Role in Cystic Fibrosis Pulmonary Exacerbation Management?
    Gavioli EM; Guardado N; Haniff F; Deiab N; Vider E
    Microb Drug Resist; 2021 Dec; 27(12):1726-1732. PubMed ID: 34077286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro investigation of the antibacterial activity of agents which may be used for the oral treatment of lung infections in CF patients.
    Richards RM; Hamilton VE; Thomas MR
    J Antimicrob Chemother; 1998 Aug; 42(2):171-8. PubMed ID: 9738834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of doripenem (S-4661) against multidrug-resistant gram-negative bacilli isolated from patients with cystic fibrosis.
    Chen Y; Garber E; Zhao Q; Ge Y; Wikler MA; Kaniga K; Saiman L
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2510-1. PubMed ID: 15917558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis.
    King P; Lomovskaya O; Griffith DC; Burns JL; Dudley MN
    Antimicrob Agents Chemother; 2010 Jan; 54(1):143-8. PubMed ID: 19805554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species.
    LiPuma JJ; Rathinavelu S; Foster BK; Keoleian JC; Makidon PE; Kalikin LM; Baker JR
    Antimicrob Agents Chemother; 2009 Jan; 53(1):249-55. PubMed ID: 18955531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients.
    Sajjan US; Tran LT; Sole N; Rovaldi C; Akiyama A; Friden PM; Forstner JF; Rothstein DM
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3437-44. PubMed ID: 11709321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of Antibiotics against Staphylococcus aureus in an
    Diaz Iglesias Y; Wilms T; Vanbever R; Van Bambeke F
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036685
    [No Abstract]   [Full Text] [Related]  

  • 28. Activity of AMP2041 against human and animal multidrug resistant Pseudomonas aeruginosa clinical isolates.
    Cabassi CS; Sala A; Santospirito D; Alborali GL; Carretto E; Ghibaudo G; Taddei S
    Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):17. PubMed ID: 28335779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm.
    Pollini S; Di Pilato V; Landini G; Di Maggio T; Cannatelli A; Sottotetti S; Cariani L; Aliberti S; Blasi F; Sergio F; Rossolini GM; Pallecchi L
    PLoS One; 2018; 13(10):e0203941. PubMed ID: 30273348
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Grohs P; Taieb G; Morand P; Kaibi I; Podglajen I; Lavollay M; Mainardi JL; Compain F
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiology of airway disease in a cohort of patients with cystic fibrosis.
    Lambiase A; Raia V; Del Pezzo M; Sepe A; Carnovale V; Rossano F
    BMC Infect Dis; 2006 Jan; 6():4. PubMed ID: 16405721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in ceftazidime-avibactam activity against multidrug-resistant organisms recovered from respiratory samples of cystic fibrosis patients.
    Farfour E; Trochu E; Devin C; Cardot Martin E; Limousin L; Roux A; Picard C; Jolly E; Vasse M; Lesprit P
    Transpl Infect Dis; 2018 Oct; 20(5):e12955. PubMed ID: 29896802
    [No Abstract]   [Full Text] [Related]  

  • 33. Bactericidal and Fungicidal Activity of
    Gruber M; Moser I; Nagl M; Lackner M
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of reference dilution test methods for antimicrobial susceptibility testing of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis.
    Saiman L; Burns JL; Whittier S; Krzewinski J; Marshall SA; Jones RN
    J Clin Microbiol; 1999 Sep; 37(9):2987-91. PubMed ID: 10449487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement in burn wound infection and survival with antimicrobial peptide D2A21 (Demegel).
    Chalekson CP; Neumeister MW; Jaynes J
    Plast Reconstr Surg; 2002 Apr; 109(4):1338-43. PubMed ID: 11964988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loci Encoding Compounds Potentially Active against Drug-Resistant Pathogens amidst a Decreasing Pool of Novel Antibiotics.
    Basalla J; Chatterjee P; Burgess E; Khan M; Verbrugge E; Wiegmann DD; LiPuma JJ; Wildschutte H
    Appl Environ Microbiol; 2019 Dec; 85(23):. PubMed ID: 31540982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial Peptides against Multidrug-Resistant
    Ben Hur D; Kapach G; Wani NA; Kiper E; Ashkenazi M; Smollan G; Keller N; Efrati O; Shai Y
    J Med Chem; 2022 Jul; 65(13):9050-9062. PubMed ID: 35759644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.
    Schneider EK; Azad MA; Han ML; Tony Zhou Q; Wang J; Huang JX; Cooper MA; Doi Y; Baker MA; Bergen PJ; Muller MT; Li J; Velkov T
    ACS Infect Dis; 2016 Jul; 2(7):478-88. PubMed ID: 27626100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myxinidin-Derived Peptide against Biofilms Caused by Cystic Fibrosis Emerging Pathogens.
    Bellavita R; Maione A; Braccia S; Sinoca M; Galdiero S; Galdiero E; Falanga A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial activity of mul-1867, a novel antimicrobial compound, against multidrug-resistant Pseudomonas aeruginosa.
    Tetz G; Vikina D; Tetz V
    Ann Clin Microbiol Antimicrob; 2016 Mar; 15():19. PubMed ID: 27001074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.